| Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery K Mitsuya, Y Nakasu, S Horiguchi, H Harada, T Nishimura, E Bando, ... Journal of neuro-oncology 99, 81-88, 2010 | 216 | 2010 |
| Metastatic skull tumors: MRI features and a new conventional classification K Mitsuya, Y Nakasu, S Horiguchi, H Harada, T Nishimura, S Yuen, ... Journal of neuro-oncology 104, 239-245, 2011 | 173 | 2011 |
| α-type-1 polarized dendritic cell-based vaccination in recurrent high-grade glioma: a phase I clinical trial Y Akiyama, C Oshita, A Kume, A Iizuka, H Miyata, M Komiyama, ... BMC cancer 12, 1-10, 2012 | 115 | 2012 |
| Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure T Shukuya, T Takahashi, T Naito, R Kaira, A Ono, Y Nakamura, A Tsuya, ... Lung Cancer 74 (3), 457-461, 2011 | 115 | 2011 |
| Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma T Ashizawa, H Miyata, A Iizuka, M Komiyama, C Oshita, A Kume, ... International journal of oncology 43 (1), 219-227, 2013 | 110 | 2013 |
| Antitumor effect of programmed death-1 (PD-1) blockade in humanized the NOG-MHC double knockout mouse T Ashizawa, A Iizuka, C Nonomura, R Kondou, C Maeda, H Miyata, ... Clinical Cancer Research 23 (1), 149-158, 2017 | 100 | 2017 |
| Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis K Mitsuya, Y Nakasu, T Kurakane, N Hayashi, H Harada, K Nozaki Journal of neurosurgery 127 (2), 433-437, 2017 | 76 | 2017 |
| Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients Y Akiyama, M Komiyama, H Miyata, M Yagoto, T Ashizawa, A Iizuka, ... Oncology reports 31 (4), 1683-1690, 2014 | 70 | 2014 |
| A T-cell–engaging B7-H4/CD3-bispecific Fab-ScFv antibody targets human breast cancer A Iizuka, C Nonomura, T Ashizawa, R Kondou, K Ohshima, T Sugino, ... Clinical Cancer Research 25 (9), 2925-2934, 2019 | 69 | 2019 |
| Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas S Deguchi, T Oishi, K Mitsuya, Y Kakuda, M Endo, T Sugino, N Hayashi Scientific reports 10 (1), 10113, 2020 | 61 | 2020 |
| Feasibility of proton beam therapy for chordoma and chondrosarcoma of the skull base H Fuji, Y Nakasu, Y Ishida, S Horiguchi, K Mitsuya, H Kashiwagi, ... Skull Base 21 (03), 201-206, 2011 | 61 | 2011 |
| Glutamate receptor antagonists and benzodiazepine inhibit the progression of granule cell dispersion in a mouse model of mesial temporal lobe epilepsy F Suzuki, C Heinrich, A Boehrer, K Mitsuya, K Kurokawa, M Matsuda, ... Epilepsia 46 (2), 193-202, 2005 | 59 | 2005 |
| Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line T Ashizawa, Y Akiyama, H Miyata, A Iizuka, M Komiyama, A Kume, ... International journal of oncology 45 (1), 411-418, 2014 | 52 | 2014 |
| Optimal sequence of local and EGFR-TKI therapy for EGFR-mutant non-small cell lung cancer with brain metastases stratified by number of brain metastases E Miyawaki, H Kenmotsu, K Mori, H Harada, K Mitsuya, N Mamesaya, ... International Journal of Radiation Oncology* Biology* Physics 104 (3), 604-613, 2019 | 47 | 2019 |
| Combination of a STAT3 inhibitor and an mTOR inhibitor against a temozolomide-resistant glioblastoma cell line H Miyata, T Ashizawa, A Iizuka, R Kondou, C Nonomura, T Sugino, ... Cancer genomics & proteomics 14 (1), 83-91, 2017 | 47 | 2017 |
| Persistent zinc depletion in the mossy fiber terminals in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy K Mitsuya, N Nitta, F Suzuki Epilepsia 50 (8), 1979-1990, 2009 | 45 | 2009 |
| YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line Y Akiyama, T Ashizawa, M Komiyama, H Miyata, C Oshita, M Omiya, ... Oncology Reports 32 (1), 159-166, 2014 | 43 | 2014 |
| The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line Y Akiyama, C Nonomura, T Ashizawa, A Iizuka, R Kondou, H Miyata, ... Immunology letters 190, 20-25, 2017 | 38 | 2017 |
| O6-Methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in … R Watanabe, Y Nakasu, H Tashiro, K Mitsuya, I Ito, S Nakasu, T Nakajima Brain tumor pathology 28, 127-135, 2011 | 37 | 2011 |
| Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up S Matsuo, J Watanabe, K Mitsuya, N Hayashi, Y Nakasu, M Hayashi Breast cancer research and treatment 162, 169-179, 2017 | 36 | 2017 |
